J2212 HCPCS Level II code: Injection, methylnaltrexone, 0.1 mg
J2212 is the HCPCS code for “Injection, methylnaltrexone, 0.1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2212Injection, methylnaltrexone, 0.1 mg
Short description: Methylnaltrexone injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J2212 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2013
Where J2212 sits
- 1J codesDrugs administered other than orally
- 2Active code J2212Injection, methylnaltrexone, 0.1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2212 mean?
J2212 is the HCPCS code for “Injection, methylnaltrexone, 0.1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2212?
CMS lists J2212’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2212
All J codesJ2182Injection, mepolizumab, 1 mgJ2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mgJ2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mgJ2185Injection, meropenem, 100 mgJ2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)J2210Injection, methylergonovine maleate, up to 0.2 mgJ2246Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mgJ2247Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mgJ2248Injection, micafungin sodium, 1 mgJ2249Injection, remimazolam, 1 mgJ2250Injection, midazolam hydrochloride, per 1 mgJ2251Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg